版本:
中国

BRIEF-Synergy Pharmaceuticals says acceptance of SNDA for TRULANCE for treatment of adults with irritable bowel syndrome with constipation

June 7 Synergy Pharmaceuticals Inc:

* Synergy Pharmaceuticals Inc says acceptance of SNDA for Trulance for treatment of adults with irritable bowel syndrome with constipation

* Synergy Pharmaceuticals Inc says prescription drug user fee act (PDUFA) date is January 24, 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐